Clobetasol 0.05% ointment

DRUG2 trials

Sponsors

University of California, Davis, Bayer

Conditions

PsoriasisToxic Epidermal Necrolysis

Phase 1

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

WithdrawnNCT02319616

University of California, DavisToxic Epidermal Necrolysis

Start: 2016-11-30End: 2019-02-06Updated: 2019-08-09

1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

CompletedNCT03399526

Start: 2013-02-11End: 2013-05-31Updated: 2018-01-16

Related Papers

Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial

Trials2015-08-215 citations